<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00345306</url>
  </required_header>
  <id_info>
    <org_study_id>EndoUtro-HMO-CTIL</org_study_id>
    <nct_id>NCT00345306</nct_id>
  </id_info>
  <brief_title>Artificial Endometrial Preparation for Frozen Thawed Embryo Transfer Applying Either Endometrin or Utrogestan</brief_title>
  <official_title>Artificial Endometrial Preparation for Frozen Thawed Embryo Transfer Applying Either Endometrin or Utrogestan - a Clinical Comparative Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The transfer of frozen-thawed embryos can be performed in a natural ovulatory cycle or in a
      hormonally manipulated cycle with a comparable pregnancy rate of 15%-20% per ET. When a
      hormonally modulated ET cycle is scheduled,an artificial endometrial preparation is carried
      out using estrogen stimulation followed by a concomitant progesterone treatment. Two
      progestative drugs are currently used in conventional IVF treatment, Utrogetan and
      Endometrin. Although Endometrin has been be efficiently used to support the luteal phase
      after embryo transfer in IVF cycles, currently, there is no study that assess its efficacy
      for clinical use in frozen-thawed ET cycles. The present study aims to compare the outcome of
      frozen thawed ET cycles when either Endometrin or Utrogestan are used as the progestative
      substitution in an artificially prepared endometrium.
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    no patient was recruited till 1/2008
  </why_stopped>
  <start_date>March 2007</start_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy rates</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lutheal hormonal profile</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Frozen Thawed Embryo Transfer</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Comparison between two different progesterone administration</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients undergoing frozen thawed ET cycles

          2. Patient has at least two embryos suitable for transfer after thawing

          3. Age 18-35 years -

        Exclusion Criteria:

          1. Any known sensitivity to Endometrin or Utrogestan

          2. Endometrial thickness less than 7.5 mm after estrogen priming -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Alex Simon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Simon Alex</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>June 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2006</study_first_submitted>
  <study_first_submitted_qc>June 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2006</study_first_posted>
  <last_update_submitted>May 6, 2008</last_update_submitted>
  <last_update_submitted_qc>May 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2008</last_update_posted>
  <keyword>endometrial preparation</keyword>
  <keyword>Utrogestan</keyword>
  <keyword>Endometrin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

